Skip To Main Content
Yinhao Chen on Muck Rack

Yinhao Chen

As seen in: Wiley Online Library, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinhao

Contact Yinhao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SenExo‐cCCT2 Reprograms Senescence Response and Anti‐Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma

|
By Yinhao Chen, Hongyi Lin, Jinpeng Lu, Shuncang Zhu
| Wiley Online Library Verified
1 Introduction Pancreatic ductal adenocarcinoma (PDAC) is highly malignant, and chemotherapy is the first-line treatment for progressive PDAC.[1, 2] The main treatment regimens for this disease include FOLFIRINOX (a combination regimen of 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin) and AG (gemcitabine plus nab-paclitaxel).
Open in Who Shared Issue with article?

Identification of Immunogenic Cell Death-Related Signature on Prognosis and Immunotherapy in Kidney Renal Clear Cell Carcinoma

|
By Liaoning Province, Takaji Matsutani, Longchao Liu, Yinhao Chen
| Frontiers
Keywords: Immunogenic cell death, kidney renal clear cell carcinoma, Tumor immune microenvironment, Prognostic signature, Immunotherapy Citation: Jiang S, Dong Y, Wang J, Zhu Q, Yang J and Shen L (2023). Identification of Immunogenic Cell Death-Related Signature on Prognosis and Immunotherapy in Kidney Renal Clear Cell Carcinoma. Front. Immunol. 14:3659.
Open in Who Shared Issue with article?
See all 2 articles